Continue PAP Therapy – It Is Optimally Controlling Her OSA
This patient should continue positive airway pressure therapy, as her current treatment demonstrates excellent disease control with a residual AHI of 0.7 events/hour, which far exceeds the therapeutic targets for OSA management. Despite the multilevel collapse findings on DISE, the objective PAP data proves the therapy is effectively treating her condition.
Clinical Reasoning
PAP Efficacy is Proven and Optimal
Your patient's PAP data demonstrates:
- Residual AHI of 0.7 events/hour (essentially normalized)
- Median pressure of only 4.6 cmH₂O (very low, well-tolerated range)
- Minimal leak (median 0.0 L/min)
- Low maximum pressure requirement (8.0 cmH₂O)
CPAP has been shown to normalize mortality in patients with severe OSA and remains the most efficacious treatment 1. The American College of Physicians strongly recommends CPAP as initial therapy for OSA, and this patient is achieving optimal therapeutic response 2.
DISE Findings Do Not Override Treatment Success
While the DISE shows multilevel collapse (velopharynx 75%, tongue base 65%, epiglottis 75%) that improves with jaw thrust, this anatomic information is primarily useful for predicting treatment response BEFORE initiating therapy, not for changing therapy that is already working 3, 4, 5.
The jaw thrust response during DISE is meant to simulate mandibular advancement and predict MAD candidacy 4, 6. However:
- DISE is a selection tool, not a treatment monitoring tool
- Her PAP is already achieving what the jaw thrust predicted—airway patency during sleep
- The objective outcome (AHI 0.7) proves the airway is being maintained
MAD Would Be Inferior in This Case
European Respiratory Society guidelines state that mandibular advancement devices are recommended for mild to moderate OSA (Grade A recommendation) and in patients who do not tolerate CPAP 1. However:
- CPAP more effectively reduces AHI than MADs in all comparative studies 1, 2
- MADs achieve treatment success (AHI <5) in only 19-75% of patients 1
- This patient is already achieving superior control with PAP
- Switching to MAD would likely result in worse disease control
The American College of Physicians recommends MADs "as an alternative therapy to CPAP for patients who prefer MADs or for those in whom CPAP is not tolerated" 2. Neither condition applies here.
Addressing the ENT Recommendations
The ENT's suggestions appear to focus on anatomic correction rather than functional outcomes:
- "Use CPAP more regularly" - The data shows excellent adherence isn't the issue; the therapy is working
- EXCITE OSA - This is myofunctional therapy, which has insufficient evidence as primary treatment 1
- Bite alignment consultation - May be relevant if considering MAD, but unnecessary given current success
- Maxillomandibular advancement surgery - This is a major surgical intervention that European guidelines recommend only "in patients who refuse conservative treatment" 1. MMA is as efficient as CPAP but carries surgical risks 1. Why pursue surgery when conservative therapy is working optimally?
Common Pitfall to Avoid
Do not let anatomic findings from DISE override objective treatment success. The DISE shows what COULD collapse without intervention—but PAP IS the intervention, and it's preventing that collapse effectively. The residual AHI of 0.7 proves this.
Recent research confirms that DISE findings predict treatment response to alternative therapies (MAD, surgery, hypoglossal nerve stimulation) but should not be used to discontinue effective PAP therapy 5, 6.
Recommendation Algorithm
IF residual AHI <5 on PAP AND good adherence AND symptom resolution: → Continue PAP (this patient)
IF residual AHI ≥5 on optimized PAP OR poor adherence OR persistent symptoms: → Consider DISE findings to guide alternative therapy selection
IF patient refuses PAP despite good control: → Then use DISE jaw-thrust response to guide MAD candidacy 4
Quality of Life Consideration
While CPAP hasn't consistently shown quality of life improvements in trials 2, this patient's therapy is working at very low pressures (median 4.6 cmH₂O) with no leaks, suggesting excellent tolerance. There's no indication she's dissatisfied with treatment.
The priority is morbidity and mortality reduction, which CPAP achieves through normalization of respiratory events 1, 7. Her AHI of 0.7 accomplishes this goal.